secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prestige Consumer Healthcare Inc. (PBH)
CIK:        0001295947
Form:       8-K
Filed at:   2022-11-03T23:59:59+00:00
Accession:  0001295947-22-000030
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Prestige Q2 revenue $289.3M (+4.7% YoY), EPS $1.02; reaffirms FY2023 outlook
----------------------------------------------------------------------------

- Record Q2 revenue $289.3M (+4.7% YoY, +5.5% ex-currency); diluted EPS $1.02, ahead of expectations.
- International OTC segment revenue $37.2M (+51.9% YoY) driven by Hydralyte demand.
- Reduced debt by $35M; leverage ratio 3.7x; completed $50M share repurchase program.
- Reaffirms FY2023 outlook: revenue $1.12-1.13B, diluted EPS $4.18-4.23, FCF $260M+.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1295947/000129594722000030/0001295947-22-000030-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1295947/000129594722000030/pbh-20221103.htm
  HTML page:      https://secwatch.observer/filing/0001295947-22-000030

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer